Ascendis Pharma A/S (NASDAQ: ASND) today announced the pricing of its underwritten public offering of 4,166,667 American Depositary Shares (“ADSs”) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Ascendis Pharma A/S Announces Pricing of Public Offering of ADSsMarch 5, 2019 8:07 PM Pre-Open Stock Movers 03/05: (CTRP) (TGT) (LB) Higher; (AFH) (ADMS) (HOLX) Lower (more...)March 5, 2019 9:24 AM After-Hours Movers 03/04: (CTRP) (HUYA) (GME) Higher; (PS) (NVTA) (CRM) (more...)March 4, 2019 5:38 PM Ascendis Pharma (ASND) Announces Proposed $400M Public Offering of ADSsMarch 4, 2019 4:00 PM Ascendis Pharma (ASND) PT Raised to $132 at Canaccord GenuityMarch 4, 2019 2:47 PM Ascendis Pharma (ASND) PT Raised to $185 at Cantor FitzgeraldMarch 4, 2019 10:33 AM Pre-Open Stock Movers 03/04: (NITE) (ASND) (AVXL) Higher; (PLCE) (SE) (DVA) Lower (more...)March 4, 2019 9:09 AM Ascendis Pharma (ASND) Reports Positive Top-Line Results from Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency, Demonstrating Superiority on Primary EndpointMarch 4, 2019 6:35 AM